Research Article

Safety Assessment of Zigbir®: A Polyherbal Formulation in Sprague-Dawley Rats

Table 5

Clinical chemistry data (mean ± SD) of female rats after oral administration of Zigbir® for 90 days.

Parameters Control250 mg/kg500 mg/kg1000 mg/kgControl recovery1000 mg/kg recovery

Total protein (g%)7.54 ± 0.387.54 ± 0.567.83 ± 0.537.55 ± 0.467.79 ± 0.357.64 ± 0.29
Albumin (g%)3.40 ± 0.323.46 ± 0.433.18 ± 0.413.34 ± 0.483.29 ± 0.353.67 ± 0.25
Bilirubin (mg%)0.68 ± 0.070.67 ± 0.100.73 ± 0.040.64 ± 0.080.64 ± 0.090.66 ± 0.06
Blood sugar (mg%)92.10 ± 12.4888.80 ± 13.9593.80 ± 11.4883.60 ± 8.5791.80 ± 10.8991.00 ± 7.28
Triglycerides (mg%)104.70 ± 9.14105.30 ± 9.04102.50 ± 9.42106.30 ± 7.79102.40 ± 3.78105.60 ± 3.21
Cholesterol (mg%)63.20 ± 4.4761.80 ± 6.6164.50 ± 5.4864.20 ± 4.9866.20 ± 3.0365.40 ± 5.94
BUN (mg%)38.90 ± 4.8241.60 ± 4.5838.30 ± 4.9736.80 ± 5.7138.40 ± 7.3741.40 ± 4.28
Creatinine (mg%)0.98 ± 0.090.97 ± 0.120.98 ± 0.110.95 ± 0.070.97 ± 0.051.03 ± 0.10
AST(IU/L)59.90 ± 5.5161.20 ± 5.0362.50 ± 4.5563.50 ± 4.3562.20 ± 8.3265.80 ± 5.97
ALT (IU/L)43.20 ± 6.3642.40 ± 7.4438.90 ± 7.9939.50 ± 9.4439.60 ± 6.8037.60 ± 7.27
ALP (IU/L)63.90 ± 7.0666.90 ± 5.3469.60 ± 8.28108.80** ± 9.4171.00 ± 9.0871.60 ± 6.31
γGT(U/L)15.50 ± 2.9214.80 ± 4.3215.90 ± 2.8115.90 ± 3.5415.80 ± 2.3915.60 ± 3.51
LDH (IU/L)358.50 ± 33.58354.50 ± 31.02371.50 ±16.57359.60 ± 34.88334.60 ± 26.69369.80 ± 34.49
CPK (IU/L)63.70 ± 4.2263.20 ± 5.0164.50 ± 4.5062.60 ± 4.7966.40 ± 3.1365.00 ± 5.66
Sodium (mmol/L)142.10 ± 5.30138.80 ± 5.69141.80 ± 6.20139.70 ± 6.31139.40 ± 3.36136.00 ± 5.10
Chloride (mmol/L)101.90 ± 3.51101.80 ± 2.82101.40 ± 3.63101.20 ± 2.94102.40 ± 1.67102.20 ± 1.79
Potassium (mmol/L)3.73 ± 0.153.51* ± 0.143.83 ± 0.153.68 ± 0.243.77 ± 0.083.79 ± 0.06
Calcium (mg%)9.44 ± 0.609.41 ± 0.509.49 ± 0.679.47 ± 0.709.52 ± 0.509.98 ± 0.68
Phosphorus (mg%)4.23 ± 0.314.11 ± 0.274.21 ± 0.394.30 ± 0.374.34 ± 0.444.00 ± 0.50

P < 0.05 versus control group.
P < 0.01 versus control group.